BioCentury
ARTICLE | Finance

BioCryst Pharmaceuticals Inc.

January 10, 2000 8:00 AM UTC

Market value tracking: BioCryst Pharmaceuticals Inc. BioCryst (BCRX) surrendered $6.75 (24 percent) to $21.625 on Friday after issuing a statement that partner Johnson & Johnson (JNJ) is still negot...